Eik Vettorazzi
Papers
2
Total Citations
117
H-Index
2
About
Eik Vettorazzi is a leading clinical researcher in gynecologic oncology, with a focused expertise in borderline ovarian tumours (BOT). Her major contributions center on understanding how patient age and surgical staging influence prognosis in this rare ovarian malignancy. Through her pivotal work on the AGO ROBOT study—one of the largest multicenter analyses of BOT—Vettorazzi demonstrated that age-dependent differences significantly affect clinical characteristics and outcomes, with her landmark 2014 paper garnering 75 citations. She further established that incomplete surgical staging is a critical negative prognostic factor, and her 2015 sub-analysis (42 citations) systematically evaluated the impact of each individual staging procedure, providing evidence-based guidance for clinical practice. By leveraging a robust dataset of 950 patients with central pathology review, Vettorazzi’s research has directly shaped surgical decision-making and risk stratification for women with BOT. Her work bridges a crucial gap in understanding how patient age and procedural completeness interact to determine long-term outcomes, making her a respected authority in the field of ovarian cancer surgery and prognosis.
Research Focus
Key Achievements
Top Papers
- 1
- 2